GST · 8 Oct
The GST Council, in its 57th meeting on 8 October 2026, recommended omitting the arrest power in section 69 of the CGST Act, raising the prosecution threshold from ₹1 crore to ₹5 crore and cutting the general penalty from ₹25,000 to ₹10,000. It also recommended system-sanctioned refunds, refund of credit on capital goods and input services, a shorter list of blocked credits and a simpler registration for small e-commerce sellers. None of it is law yet: each item needs a circular, notification or amendment.
Relief
Licences · 8 Oct
The Government has approved a cap on the margins charged in the supply and sale of non-scheduled anti-cancer drugs, limiting them to 30% of the Maximum Retail Price, according to a Department of Pharmaceuticals release of 8 October 2026. An expert committee under the Directorate General of Health Services will finalise the list of medicines, after which NPPA will take a decision and issue the notification. Manufacturers of these drugs will be required to maintain their current production levels.
Relief
Insolvency · 7 Oct
The National Company Law Tribunal approved 107 resolution plans in the second quarter of FY 2026–27, which it says is the highest in any quarter since its inception, with an aggregate approved plan value of more than ₹11,000 crore. As on 30 September 2026, 294 resolution plans were pending for approval and orders were reserved in a further 41. The Tribunal is working with 48 Members against a sanctioned strength of 62.
